137 related articles for article (PubMed ID: 17382182)
1. Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein.
Parsons CL; Rajasekaran M; Arsanjani AH; Chenoweth M; Stein P
Urology; 2007 Mar; 69(3):577-81. PubMed ID: 17382182
[TBL] [Abstract][Full Text] [Related]
2. Tamm-Horsfall protein protects urothelial permeability barrier.
Stein P; Rajasekaran M; Parsons CL
Urology; 2005 Oct; 66(4):903-7. PubMed ID: 16230179
[TBL] [Abstract][Full Text] [Related]
3. Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis.
Parsons CL; Bautista SL; Stein PC; Zupkas P
J Urol; 2000 Oct; 164(4):1381-4. PubMed ID: 10992419
[TBL] [Abstract][Full Text] [Related]
4. Defective Tamm-Horsfall protein in patients with interstitial cystitis.
Parsons CL; Stein P; Zupkas P; Chenoweth M; Argade SP; Proctor JG; Datta A; Trotter RN
J Urol; 2007 Dec; 178(6):2665-70. PubMed ID: 17945284
[TBL] [Abstract][Full Text] [Related]
5. Toxic factors in human urine that injure urothelium.
Rajasekaran M; Stein P; Parsons CL
Int J Urol; 2006 Apr; 13(4):409-14. PubMed ID: 16734860
[TBL] [Abstract][Full Text] [Related]
6. Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis.
Akiyama A; Stein PC; Houshiar A; Parsons CL
Int J Urol; 2000 May; 7(5):176-83. PubMed ID: 10830825
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary levels of Tamm-Horsfall glycoprotein suggest a systemic etiology of interstitial cystitis.
Bade JJ; Marrink J; Karrenbeld A; van der Weele L; Mensink HJ
J Urol; 1996 Sep; 156(3):943-6. PubMed ID: 8709369
[TBL] [Abstract][Full Text] [Related]
8. Abnormal glycosylation of Tamm-Horsfall protein in patients with interstitial cystitis.
Argade SP; Vanichsarn C; Chenoweth M; Parsons CL
BJU Int; 2009 Apr; 103(8):1085-9. PubMed ID: 19007360
[TBL] [Abstract][Full Text] [Related]
9. Alterations of Tamm-Horsfall protein immunoreactivity after partial desialylation and deglycosylation.
Grabska T; Bagiński T; Kubicz A; Kokot M; Kokot F; Duława J
Arch Immunol Ther Exp (Warsz); 1996; 44(4):241-8. PubMed ID: 9017164
[TBL] [Abstract][Full Text] [Related]
10. MN-001, a novel oral anti-inflammatory agent, suppresses bladder hyperactivity in a rat model.
Rajasekaran M; Locke KW; Parsons CL
BJU Int; 2006 Aug; 98(2):430-4. PubMed ID: 16879690
[TBL] [Abstract][Full Text] [Related]
11. [Construction of urinary Tamm-Horsfall protein assay by enzyme-linked immunosorbent assay and establishment of reference range of healthy subject].
Nishimaki J; Masuda M; Katoh S; Nakajima T; Kanamori K; Shimomura H; Shiba K
Rinsho Byori; 2008 Oct; 56(10):862-7. PubMed ID: 19068782
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase inhibition suppresses potassium chloride-induced bladder hyperactivity in a rat model.
Rajasekaran M; Mehta N; Baquir A; Kuntz S
Urology; 2007 Apr; 69(4):791-4. PubMed ID: 17445683
[TBL] [Abstract][Full Text] [Related]
13. Effects of Tamm-Horsfall protein on polymorphonuclear leukocyte function.
Wimmer T; Cohen G; Saemann MD; Hörl WH
Nephrol Dial Transplant; 2004 Sep; 19(9):2192-7. PubMed ID: 15266028
[TBL] [Abstract][Full Text] [Related]
14. Renal localization of Tamm-horsfall protein in unilateral obstructive uropathy in rats.
Dziukas LJ; Sterzel RB; Hodson CJ; Hoyer JR
Lab Invest; 1982 Aug; 47(2):185-93. PubMed ID: 7050530
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model.
Gokhale JA; Glenton PA; Khan SR
J Urol; 2001 Oct; 166(4):1492-7. PubMed ID: 11547119
[TBL] [Abstract][Full Text] [Related]
16. Tamm-Horsfall protein acts as a general host-defense factor against bacterial cystitis.
Raffi HS; Bates JM; Laszik Z; Kumar S
Am J Nephrol; 2005; 25(6):570-8. PubMed ID: 16244464
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the C-terminal structure of urinary Tamm-Horsfall protein reveals that the release of the glycosyl phosphatidylinositol-anchored counterpart from the kidney occurs by phenylalanine-specific proteolysis.
Fukuoka S; Kobayashi K
Biochem Biophys Res Commun; 2001 Dec; 289(5):1044-8. PubMed ID: 11741296
[TBL] [Abstract][Full Text] [Related]
18. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes.
Chuang YC; Tyagi P; Huang CC; Yoshimura N; Wu M; Kaufman J; Chancellor MB
J Urol; 2009 Aug; 182(2):786-92. PubMed ID: 19539320
[TBL] [Abstract][Full Text] [Related]
19. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients.
Sejdiu I; Torffvit O
Scand J Urol Nephrol; 2008; 42(2):168-74. PubMed ID: 17907053
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Tamm-Horsfall protein subunits prepared in vitro, in patients with acute pyelonephritis.
Jelaković B; Benković J; Cikes N; Kuzmanić D; Roncević T; Krznarić Z
Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):315-7. PubMed ID: 8704048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
